Clinical Trial Update: Study of Enteric-coated Mycophenolate Sodium Maintenance Therapy in Patients With Renal Transplant Receiving Cyclosporine Microemulsion and Steroids, [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating enteric-coated mycophenolate sodium as maintenance therapy in kidney transplant recipients receiving cyclosporine microemulsion and ste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Mycophenolate sodium (enteric-coated) (mycophenolate sodium)
• PREDNISONE (Prednisone)
• cyclosporine microemulsion (cyclosporine)

Snippet

Sponsor: Novartis | Conditions: Maintenance Renal Transplantation | Phase 3 | Status: COMPLETED